每经头条（nbdtoutiao）——基金经理个人炒股合法吗？我们调查了多家头部公募，答案出人意料 （记者 曾健辉） 每经AI快讯，皖通高速2月6日晚间发布公告称，公司第十届第二十三次董事会会议于2026年2月6日在 合肥市望江西路520号公司会议室以现场会议和视频会议相结合的方式召开。会议审议了《关于公司 2026年度投资计划的议案》等文件。 ...

格隆汇2月6日丨皖通高速(600012.SH)公布，为满足区域交通运输发展需求，提升道路通行效率与服务 水平，增强G30连霍高速公路安徽段（下称"连霍高速"）在路网中的竞争能力，促进沿线地区经济社会 高质量发展和本公司健康可持续发展，公司拟投资连霍高速改扩建工程项目。本项目估算总投资金额约 为人民币54.2亿元，其中资本金约为人民币10.84亿元，占总投资的20%，为公司自有资金，其余43.36 亿元由公司通过国内银行贷款等方式解决。 ...

Group 1 - ZTE Corporation plans to invest 200 million RMB to subscribe to the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Guidance Fund, focusing on areas supported by national policies such as new generation information technology and biotechnology [1] - Huayi Jewelry's subsidiary has reported overdue loans totaling 200 million RMB due to tight liquidity, with a cumulative overdue principal of 254 million RMB [2] - Guangzhou Baiyunshan Pharmaceutical's subsidiary has received approval for the consistency evaluation of Alfacalcidol soft capsules, which are used to treat calcium metabolism disorders [3] Group 2 - Kunming Pharmaceutical Group reported a 21.72% decline in revenue to 6.577 billion RMB and a 46% drop in net profit to 350 million RMB for 2025 [4] - Jiantou Energy's application for a specific stock issuance has been approved by the Shenzhen Stock Exchange [5] - Jinchuan Titanium Industry's subsidiary has temporarily suspended its sulfuric acid production due to reduced demand [6] Group 3 - Kelun Pharmaceutical's subsidiary has received approval for a new indication for its antibody-drug conjugate, which is used to treat advanced hormone receptor-positive breast cancer [7] - Fawer Co., Ltd. has completed the relocation of its Chongqing Yuantai Shock Absorber Company and commenced production [8] - Jiuzhoutong's subsidiary has received acceptance for the listing application of Betahistine Hydrochloride tablets [9] Group 4 - Zhongguancun plans to build a traditional Chinese medicine and raw material drug production base in Jiamusi City, Heilongjiang Province [11] - China Wuyi announced that part of its land in Kenya has been requisitioned by the government, with compensation of approximately 6.25 million RMB [12] - Times Electric reported a 15.46% increase in revenue to 28.761 billion RMB and a 10.88% increase in net profit to 4.105 billion RMB for 2025 [13] Group 5 - Top Cloud Agriculture's shareholder has received regulatory measures from the Zhejiang Securities Regulatory Bureau for failing to timely disclose shareholding changes [14] - Xinwanda's subsidiary has reached a settlement in a lawsuit involving over 2.314 billion RMB, with an estimated impact of 500 to 800 million RMB on net profit for 2025 [15] - Dongrui Co., Ltd. reported a 25.19% increase in pig sales revenue in January, totaling 214 million RMB [16] Group 6 - Tianjin Tianshi reported a 3.08% decline in revenue to 8.236 billion RMB, while net profit increased by 15.68% to 1.105 billion RMB for 2025 [17] - Wantong Expressway plans to invest approximately 5.42 billion RMB in the renovation and expansion of the Lianhuo Expressway [18] - Qiaoyin Co., Ltd. has pre-qualified for a sanitation integration service project worth approximately 73.8 million RMB [20] Group 7 - Jindi Co., Ltd. plans to acquire 100% equity of Yuni Precision for 116 million RMB, focusing on precision stamping products [21] - Heng Rui Medicine's HRS-4642 injection has been included in the list of breakthrough therapeutic varieties [22] - Tongde Chemical has had some assets frozen due to a financing lease dispute [23] Group 8 - Zhongli Co., Ltd. is establishing an industrial fund with a total commitment of approximately 408.76 million RMB, focusing on new materials and artificial intelligence [24] - Tianbang Food reported a 9.93% increase in pig sales revenue in January, totaling 674 million RMB [25] - New Hope reported a 10.03% decrease in pig sales revenue in January, totaling 1.628 billion RMB [26] Group 9 - Tainkang's subsidiary has received a drug registration certificate for Minoxidil topical solution [27] - Lihua Co., Ltd. reported a 9.8% increase in chicken sales revenue in January, totaling 1.289 billion RMB [28] - Guojitong General reported a 45.71% increase in net profit to 58.52 million RMB for 2025 [29] Group 10 - Zhixin Co., Ltd. plans to invest up to 1.1 billion RMB in an automotive stamping and welding parts project [30] - Chuangyuan Technology's subsidiary has pre-qualified for a National Grid project worth approximately 94.77 million RMB [31] - Lisheng Pharmaceutical's adenine phosphate raw material has passed the listing application [32] Group 11 - Tongguang Cable's subsidiary has pre-qualified for a National Grid project worth approximately 108 million RMB [33] - Zhenghong Technology reported a 7.74% increase in pig sales revenue in January, totaling 14.35 million RMB [34] - Pengding Holdings reported a 0.07% decrease in consolidated revenue in January, totaling 2.701 billion RMB [35] Group 12 - Hongri Pharmaceutical has received approval for clinical trials of its injectable drug for acute pancreatitis [36][37] - Xinhua Medical has decided to terminate the acquisition of a 36.19% stake in Wuhan Zhongzhi Biotechnology [38] - Tianyu Bio reported an 11.23% decrease in pig sales revenue in January, totaling 54.29 million RMB [39]

| 证券代码：600012 | 证券简称：皖通高速 | | | 公告编号：临 | 2026-005 | | --- | --- | --- | --- | --- | --- | | 债券代码：242121 | 债券简称：24 | 皖通 | 01 | | | | 债券代码：242467 | 债券简称：25 | 皖通 | V1 | | | | 债券代码：242468 | 债券简称：25 | 皖通 | V2 | | | 安徽皖通高速公路股份有限公司 关于投资 G30 连霍高速公路安徽段改扩建工程的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 投资标的名称：G30 连霍高速公路安徽段改扩建工程 ● 投资金额：根据工程可行性研究报告，本项目估算总投资金额约为人民 币 54.2 亿元，其中资本金约为人民币 10.84 亿元，占总投资的 20%，为公司自有 资金，其余 43.36 亿元由公司通过国内银行贷款等方式解决。 | | □新设公司 | | --- | --- | | | □增资现有公司（□同比例 □非 ...

| 证券代码：600012 | 证券简称：皖通高速 | | | 公告编号：临 | 2026-004 | | --- | --- | --- | --- | --- | --- | | 债券代码：242121 | 债券简称：24 | 皖通 | 01 | | | | 债券代码：242467 | 债券简称：25 | 皖通 | V1 | | | | 债券代码：242468 | 债券简称：25 | 皖通 | V2 | | | 安徽皖通高速公路股份有限公司 第十届董事会第二十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 （一）安徽皖通高速公路股份有限公司（以下简称"本公司"或"公司"）于 2026 年 2 月 6 日（星期五）上午 9:30 在合肥市望江西路 520 号公司会议室以现场会 议和视频会议相结合的方式召开第十届董事会第二十三次会议。 （二）会议通知和会议材料分别于 2026 年 1 月 27 日和 2026 年 1 月 30 日以 电子邮件方式发送给各位董事和高级管理人员。 （三）会 ...

Market Overview - AMD's overnight drop of 17% triggered a significant decline in chip stocks, leading to a 1.95% drop in the Chinese concept index, which negatively impacted the Hong Kong stock market [1] - The Hang Seng Index fell by 340.88 points, or 1.27%, to 26,506.44 points, while the Hang Seng Tech Index decreased by 62.30 points, or 1.16%, to 5,304.14 points [1] - Major tech stocks like Tencent and Alibaba saw declines of nearly 3% and 2.5%, respectively, with Tencent's market value dropping below 500 billion [1] Company Performance - Xinda Biopharmaceuticals (01801.HK) projected total product revenue of approximately RMB 11.9 billion for 2025, reflecting a year-on-year growth of about 45% [2] - Lee & Man Paper Manufacturing (02314.HK) expects profits for 2025 to be between HKD 1.88 billion and HKD 2.00 billion, indicating a year-on-year increase of 38% to 47% [2] - ZTO Express (02057.HK) anticipates total revenue of RMB 48.5 billion to RMB 50 billion for 2025, representing a year-on-year growth of approximately 9.5% to 12.9% [2] - China Resources Cement (01313.HK) forecasts a year-on-year profit increase of about 115% to 135% for 2025, driven by reduced costs and impairment losses [2] Corporate Actions - Goldin Properties (00535.HK) reported a January contract sales total of approximately RMB 239 million, a year-on-year decrease of 61.82% [3] - Fosun International (00656.HK) plans to subscribe for additional registered capital of RMB 105 million in Shangmeng Technology, acquiring a 51.0879% stake post-increase [3] - Shanghai Pharmaceuticals (02607.HK) intends to publicly transfer its 30% stake in Bristol-Myers Squibb, with a minimum listing price of approximately RMB 1.023 billion [3] - China Coalbed Methane (08270.HK) completed the sale of 100% equity in Shanxi Qingshui Shuntai Energy Development [4] Investment Trends - The active repurchase of shares continues, with Kingsoft (03888.HK) repurchasing 1.0886 million shares for approximately HKD 29.99 million [9] - Xiaomi Group (01810.HK) repurchased 4.3 million shares for a total of HKD 146 million [10] - Kingdee International (00268.HK) repurchased 1 million shares for approximately HKD 11.1 million [11] Market Outlook - Guoyuan International's report suggests that the Hong Kong stock market may experience short-term volatility due to external factors, but maintains a positive long-term outlook [12] - CITIC Securities highlights the potential for new investment opportunities in emerging markets, despite risks from rising oil prices and long-term bond yields [12] - Galaxy Securities recommends focusing on technology, energy, precious metals, and consumer sectors for potential rebounds [13]

Core Viewpoint - The company has announced a share transfer agreement where its controlling shareholder, Shandong Expressway Group Co., Ltd., will transfer 7% of its shares to Anhui Wantong Expressway Co., Ltd. at a price of 8.92 CNY per share, totaling approximately 3.02 billion CNY [1][2]. Group 1: Share Transfer Agreement Details - On October 21, 2025, the controlling shareholder, Shandong Expressway Group, signed a share transfer agreement with Anhui Wantong Expressway, agreeing to transfer 338,419,957 shares, which represent 7% of the company's total share capital, through a private agreement [3]. - The share transfer has received compliance confirmation from the Shanghai Stock Exchange and the share transfer registration procedures have been completed, with the transfer date set for February 3, 2026 [4]. Group 2: Post-Transfer Arrangements - Anhui Wantong Expressway has committed not to trade or transfer the acquired shares for 12 months after the shares are registered in its name. Following the completion of the share transfer, it has the right to nominate or recommend one director [2]. - The share transfer does not trigger a mandatory bid and will not result in changes to the controlling shareholder or actual controller, nor will it significantly impact the company's governance structure or ongoing operations [2].

Core Viewpoint - The company, Anhui Expressway, is focusing on expanding its investment in the highway sector to strengthen and grow its core business sustainably through a strategic acquisition of shares in Shandong Expressway [1] Group 1: Acquisition Details - Anhui Expressway has acquired 7% of the total shares of Shandong Expressway, amounting to 338,419,957 shares, from Shandong High Group [1] - The acquisition was executed through a non-public agreement at a price of 8.92 yuan per share, totaling approximately 3.02 billion yuan [1] - The share transfer agreement was signed on October 21, 2025, and the transfer was completed on February 3, 2026, with the shares being unrestricted tradable [1] Group 2: Corporate Governance - The company held its 17th meeting of the 10th Board of Directors and the 10th meeting of the 10th Supervisory Board on October 21, 2025, to review the acquisition proposal [1] - A temporary shareholders' meeting was convened on December 30, 2025, to approve the acquisition of shares in Shandong Expressway [1] - The transaction has received compliance confirmation from the Shanghai Stock Exchange and a securities transfer registration confirmation from China Securities Depository and Clearing Corporation Limited [1]

Group 1 - The core point of the article is that Shandong Expressway announced the transfer of approximately 338 million unrestricted circulating shares, representing 7% of the company's total share capital, from its controlling shareholder, Gaosu Group, to Anhui Expressway through a private agreement [1] - The share transfer agreement was signed on October 21, 2025, and has received compliance confirmation from the Shanghai Stock Exchange [1] - The transfer was officially registered on February 4, 2026, with the transfer date set for February 3, 2026, and all registration procedures have been completed [1]

安徽皖通高速公路股份有限公司 ANHUI EXPRESSWAY COMPANY LIMITED （於中華人民共和國註冊成立的股份有限公司） （股份編號： 995） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致之任何損失承擔任何責任。 截止本公告日，本公司董事會成員包括執行董事汪小文（主席）、余泳及陳季平；非 執行董事楊旭東及楊建國；獨立非執行董事章劍平、盧太平及趙建莉；以及職工董 事吳長明。 | 证券代码：600012 | 证券简称：皖通高速 | | | 公告编号：临 | 2026-003 | | --- | --- | --- | --- | --- | --- | | 债券代码：242121 | 债券简称：24 | 皖通 | 01 | | | | 债券代码：242467 | 债券简称：25 | 皖通 | V1 | | | | 债券代码：242468 | 债券简称：25 | 皖通 | V2 | | | 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13. ...